+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Plasma Fractionation Market by Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor), Application (Immunology, Hematology, Critical Care, Rheumatology, Pulmonology), End User (Hospitals & Clinics) - Global Forecast to 2025

  • ID: 5146177
  • Report
  • September 2020
  • Region: Global
  • 269 Pages
  • Markets and Markets
1 of 6
The Hospitals and Clinics Segment is Expected to Dominate the Market During the Forecast Period.

FEATURED COMPANIES

  • Biotest (Germany)
  • Centurion Pharma (Turkey)
  • CSL (Australia)
  • Grifols (Spain)
  • KabaFusion (US)
  • Kedrion (Italy)
  • MORE

“Growing use of immunoglobulins in various therapeutic areas, increase in plasma collection (and the number of plasma collection centers), and the growing prevalence of respiratory diseases and alpha-1-antitrypsin deficiency (AATD) is expected to drive the overall growth of the plasma fractionation market.”

The global plasma fractionation market size is projected to reach USD 39.5 billion by 2025 from USD 28.6 billion in 2020, at a CAGR of 6.7% during the forecast period. Growth in the plasma fractionation market is primarily driven by factors such as growing use of immunoglobulins in various therapeutic areas, increase in plasma collection (and the number of plasma collection centers), rising geriatric population, and the growing prevalence of respiratory diseases and alpha-1-antitrypsin deficiency (AATD). However, the high cost of plasma products, limited reimbursements, and the emergence of recombinant alternatives are expected to restrain the growth of this market to a certain extent during the forecast period.

Based on end user, the plasma fractionation market is segmented into hospitals and clinics, clinical research laboratories, and academic institutes. In 2019, the hospitals and clinics segment accounted for the largest share of the global plasma fractionation market. The large share of this segment is attributed to the increasing adoption of plasma products in the treatment of various diseases, large patient pool treated in hospitals, and the increasing number of hospitals and clinics across the globe.

“The pulmonology application segment will witness the highest growth in the plasma fractionation market.”

Based on application, the plasma fractionation market is segmented into neurology, immunology, hematology, critical care, pulmonology, hemato-oncology, rheumatology, and other applications. In 2019, the pulmonology segment is expected to register the highest CAGR during the forecast period. Growth in this market segment is driven largely by the rising prevalence of alpha-1 antitrypsin deficiency and chronic obstructive pulmonary disease (copd).

“North America will dominate the market during the forecast period.”

Geographically, the plasma fractionation market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest share of the plasma fractionation market, followed by Europe and the Asia Pacific. The large share of North America in the global market is attributed to the growing use of immunoglobulins in various therapeutic areas, growing geriatric population, and the increasing prevalence of respiratory diseases and AATD.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 37%, Tier 2: 23%, and Tier 3: 40%
  • By Designation - C-level: 32%, D-level: 26%, and Others: 42%
  • By Region - North America: 35%, Europe: 25%, Asia Pacific: 20%, Latin America: 12%, and the Middle East and Africa: 8%

List of Companies Profiled in the Report

  • CSL (Australia)
  • Grifols (Spain)
  • Shire (Ireland)
  • Octapharma (Switzerland)
  • Kedrion (Italy)
  • LFB (France)
  • Biotest (Germany)
  • Sanquin (Netherlands)
  • China Biologic Products (UK)
  • Bio Products Laboratory (UK)
  • Japan Blood Products Organization (Japan)
  • Green Cross Corporation (South Korea)
  • Shanghai RAAS Blood Products (China)
  • Emergent BioSolutions (US)
  • Intas Biopharmaceuticals (India)
  • Bharat Serums and Vaccines Limited (India)
  • SK Plasma (Republic of Korea)
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China)
  • KabaFusion (US)
  • Centurion Pharma (Turkey)

Research Coverage:

This report provides a detailed picture of the global plasma fractionation market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user, and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total plasma fractionation market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on plasma fractionation offered by the top 25 players in the plasma fractionation market. The report analyses the plasma fractionation market by product, application, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various plasma fractionation across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the plasma fractionation market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the plasma fractionation market.
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Biotest (Germany)
  • Centurion Pharma (Turkey)
  • CSL (Australia)
  • Grifols (Spain)
  • KabaFusion (US)
  • Kedrion (Italy)
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.3 Scope of the Study
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
Table 1 Standard Currency Conversion Rate
1.5 Stakeholders
1.6 Summary of Changes

2 Research Methodology
2.1 Research Approach
Figure 1 Research Design
2.1.1 Secondary Sources
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Primary Sources
2.1.2.2 Key Data from Primary Sources
Figure 2 Supply Side: Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.2 Market Size Estimation
Figure 3 Market Size Estimation: Revenue Share Analysis
Figure 4 Market Size Estimation: Plasma Fractionation Market
2.3 Market Breakdown and Data Triangulation
Figure 5 Data Triangulation Methodology
2.4 Market Share Estimation
Figure 6 Assumptions for the Study
Figure 7 Limitations of the Study

3 Executive Summary
Figure 8 Plasma Fractionation Market, by Product, 2020 Vs. 2025 (USD Million)
Figure 9 Plasma Fractionation Market, by Application,2020 Vs. 2025 (USD Million)
Figure 10 Plasma Fractionation Market, by End-user, 2020 Vs. 2025 (USD Million)
Figure 11 Geographical Snapshot of the Plasma Fractionation Market

4 Premium Insights
4.1 Plasma Fractionation Market Overview
Figure 12 Growing Use of Immunoglobulins in Various Therapeutic Areas is the Major Factor Driving Market Growth
4.2 North America: Plasma Fractionation Market, by Product & Country (2019)
Figure 13 Immunoglobulins Segment Accounted for the Largest Share of the North American Plasma Fractionation Market in 2019
4.3 Plasma Fractionation Market: Geographic Growth Opportunities
Figure 14 China to Register the Highest CAGR in the Plasma Fractionation Market During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Table 2 Plasma Fractionation Market: Impact Analysis
5.2.1 Market Drivers
5.2.1.1 Growing Use of Immunoglobulins in Various Therapeutic Areas
Table 3 On-Label and Off-Label Indications of IVIG
Table 4 Number of Clinical Studies on Immunoglobulins, by Region (As of July 2020)
Table 5 Number of Patients Treated for Top 10 Target Conditions in the UK
5.2.1.2 Rising Geriatric Population
Table 6 Geriatric Population, by Region, 2000-2050
5.2.1.3 Growing Prevalence of Respiratory Diseases and AATD
Figure 15 Global Percentage of Deaths from Respiratory Diseases
5.2.2 Market Restraints
5.2.2.1 High Cost and Limited Reimbursement
5.2.2.2 Emergence of Recombinant Alternatives
5.2.3 Market Opportunities
5.2.3.1 Increased Risk of Pandemics and Communicable Diseases
5.2.3.2 Rising Prevalence of Bleeding Disorders
Figure 16 Number of Hemophilia a and Hemophilia B Patients Worldwide, 2012-2018
Table 7 Number of Hemophilia Patients in Developed and Emerging Countries, 2016 Vs. 2018
5.2.4 Market Challenges
5.2.4.1 Stringent Government Regulations

6 Industry Insights
6.1 Introduction
6.2 Key Industry Trends
6.2.1 Focus on Increasing Fractionation Capacities
Table 8 Fractionation Capacity Expansions by Major Players
6.2.2 New Indications for Plasma Products
6.2.3 Rising Adoption of Scig
6.2.4 Increasing Number of Fractionator-Owned Plasma Collection Centers
6.2.5 Growing Plasma Products Market in China
Figure 17 Plasma Fractionation Market in China Vs. the US, 2018-2025
Table 9 China: Top Players in the Plasma Fractionation Market, 2019
Table 10 Major Local Players in China
6.2.6 Increasing Focus of Plasma Fractionators Towards Manufacturing and Developing Recombinant Factors
Table 11 Regional Impact Analysis of Recombinant Factors on Plasma-Derived Products
6.3 Porter's Five Forces
Figure 18 Porter's Five Forces Analysis
6.3.1 Threat of New Entrants
6.3.2 Threat of Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry
6.4 Vendor Benchmarking
6.4.1 Product Portfolio Analysis: Plasma Fractionation Market
6.4.2 Number of Plasma Collection Centers and Fractionation Capacities, by Key Player
6.4.3 Business Presence of Key Players in the Value Chain
6.5 Pricing Analysis
Table 12 Average Selling Price of Plasma Fractionation Products, by Player (2019)
Table 13 Average Selling Price of Plasma Fractionation Products, by Region (2019)
6.6 Plasma Collection
Figure 19 Source Plasma Collection in the US, 2008-2019
Figure 20 Plasma Collection Centers in the US, 2005-2018
Figure 21 Europe: Plasma Collection, 2007-2019
Table 14 Number of Plasma Collection Centers, by Company, 2019
Table 15 Plasma Collection, by Region, 2018-2025 (Million Liter)
Table 16 North America: Plasma Collection, by Country, 2018-2025 (Million Liter)
6.7 Impact of COVID-19 on the Plasma Fractionation Market
Table 17 COVID-19- Clinical Trials with Key Findings
Table 18 Clinical Trials of Convalescent Plasma Expected to Complete this Year

7 Plasma Fractionation Market, by Product
7.1 Introduction
Table 19 Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
7.2 Immunoglobulins
Table 20 IVIG Vs. SCIG Therapy
Table 21 Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 22 Immunoglobulins Market, by Country, 2018-2025 (USD Million)
7.2.1 Intravenous Immunoglobulins
7.2.1.1 IVIG Holds the Largest Share of the Immunoglobulins Market
Table 23 Intravenous Immunoglobulins Offered by Key Market Players
Table 24 Intravenous Immunoglobulins Market, by Country, 2018-2025 (USD Million)
Table 25 Intravenous Immunoglobulins Market, by Region, 2018-2025 (Metric Tons)
7.2.2 Subcutaneous Immunoglobulins
7.2.2.1 Benefit of Self-Administration and Lower Incidence of Non-Serious Systemic Adverse Reactions Will Drive the Growth of the Scig Market
Table 26 Subcutaneous Immunoglobulins Offered by Key Market Players
Table 27 Subcutaneous Immunoglobulins Market, by Country, 2018-2025 (USD Million)
Table 28 Subcutaneous Immunoglobulins Market, by Region, 2018-2025 (Metric Tons)
7.2.3 Other Immunoglobulins
Table 29 Other Immunoglobulins Offered by Key Market Players
Table 30 Other Immunoglobulins Market, by Country, 2018-2025 (USD Million)
Table 31 Other Immunoglobulins Market, by Region, 2018-2025 (Million International Units)
7.3 Coagulation Factor Concentrates
Table 32 Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 33 Coagulation Factor Concentrates Market, by Country, 2018-2025 (USD Million)
7.3.1 Factor Viii
7.3.1.1 Factor Viii Holds the Largest Share of the Coagulation Factor Concentrates Market
Table 34 Factor Viii Offered by Key Market Players
Table 35 Factor Viii Market, by Country, 2018-2025 (USD Million)
Table 36 Factor Viii Market, by Region, 2018-2025 (Million International Units)
7.3.2 Factor Ix
7.3.2.1 Rising Number of Hemophilic Patients is Expected to Drive the Growth of this Market
Table 37 Factor Ix Offered by Key Market Players
Table 38 Factor Ix Market, by Country, 2018-2025 (USD Million)
Table 39 Factor Ix Market, by Country, 2018-2025 (Million International Unit)
7.3.3 Von Willebrand Factor
7.3.3.1 Market Growth is Primarily Driven by the Increasing Prevalence and Diagnosis of Von Willebrand Disease and Hemophilia
Table 40 Von Willebrand Factor Offered by Key Market Players
Table 41 Von Willebrand Factor Market, by Country, 2018-2025 (USD Million)
Table 42 Von Willebrand Factor Market, by Country, 2018-2025 (Million International Unit)
7.3.4 Prothrombin Complex Concentrates
7.3.4.1 Advantages of Pcc Over Fresh Frozen Plasma Will Support Market Growth in this Segment
Table 43 Prothrombin Complex Concentrates Offered by Key Market Players
Table 44 Prothrombin Complex Concentrates Market, by Country, 2018-2025 (USD Million)
Table 45 Prothrombin Complex Concentrates Market, by Country, 2018-2025 (Million International Unit)
7.3.5 Fibrinogen Concentrates
7.3.5.1 Safety Profile, Accuracy, and Speed of Administration Are Supporting the Growth of the Fibrinogen Concentrates Market
Table 46 Fibrinogen Concentrates Offered by Key Market Players
Table 47 Fibrinogen Concentrates Market, by Country, 2018-2025 (USD Million)
Table 48 Fibrinogen Concentrates Market, by Country, 2018-2025 (Million International Unit) 110
7.3.6 Factor Xiii
7.3.6.1 Applications in Treating Rare Bleeding Disorders Will Contribute to the Demand for Factor Xiii
Table 49 Factor Xiii Offered by Key Market Players
Table 50 Factor Xiii Market, by Country, 2018-2025 (USD Million)
Table 51 Factor Xiii Market, by Country, 2018-2025 (Million International Unit)
7.4 Albumins
7.4.1 Rising Demand for Albumin as An Antioxidant to Drive Market Growth
Table 52 Albumins Offered by Key Market Players
Table 53 Albumins Market, by Country, 2018-2025 (USD Million)
Table 54 Albumins Market, by Region, 2018-2025 (Million International Unit)
7.5 Protease Inhibitors
7.5.1 Rising Prevalence of Copd Will Drive the Demand for Protease Inhibitors
Table 55 Protease Inhibitors Offered by Key Market Players
Table 56 Protease Inhibitors Market, by Country, 2018-2025 (USD Million)
Table 57 Protease Inhibitors Market, by Country, 2018-2025 (Million International Unit)
7.6 Other Products
Table 58 Other Products Market, by Country, 2018-2025 (USD Million)

8 Plasma Fractionation Market, by Application
8.1 Introduction
Table 59 Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
8.2 Neurology
8.2.1 Rising Prevalence of Major Age-Related Neurological Disorders to Drive Market Growth
Table 60 Number of Dalys for Neurological Disorders and the Percentage of Dalys Projected for 2005, 2015, and 2030
Table 61 Plasma-Derived Products and Their Applications in Neurology
Table 62 Plasma Fractionation Market for Neurology, by Country, 2018-2025 (USD Million)
8.3 Immunology
8.3.1 Increasing Prevalence of Immunodeficiency Disorders Among Children and Adults to Drive the Growth of this Market
Table 63 List of Fda-Approved Indications for Immunoglobulins in Immunology
Table 64 Diagnosis Distribution of Different Categories of Primary Immunodeficiency Disease
Table 65 Prevalence of Primary Immunodeficiency Disease, by Region, 2013 Vs. 2015
Table 66 Plasma-Derived Products and Their Applications in Immunology
Table 67 Plasma Fractionation Market for Immunology, by Country, 2018-2025 (USD Million)
8.4 Hematology
8.4.1 Growth in the Number of Hemophilia Patients to Drive the Demand for Coagulation Factor Concentrates and Immunoglobulins
Table 68 Number of Hemophilia Patients (2012-2018)
Table 69 Plasma-Derived Products and Their Applications in Hematology
Table 70 Plasma Fractionation Market for Hematology, by Country, 2018-2025 (USD Million)
8.5 Critical Care
8.5.1 Increasing Off-Label Use of Albumin and Rising Use of Anticoagulants to Drive the Demand for Plasma-Derived Critical Care Products
Table 71 Plasma-Derived Products and Their Applications in Critical Care
Table 72 Plasma Fractionation Market for Critical Care, by Country, 2018-2025 (USD Million)
8.6 Pulmonology
8.6.1 Rising Prevalence of Alpha-1 Antitrypsin Deficiency and Copd to Drive the Plasma Fractionation Market for Pulmonology
Table 73 Plasma-Derived Products and Their Applications in Pulmonology
Table 74 Plasma Fractionation Market for Pulmonology, by Country, 2018-2025 (USD Million)
8.7 Hemato-Oncology
8.7.1 Rising Number of Blood Cancer Patients to Drive the Demand for Plasma-Derived Products
Table 75 Incidence of Leukemia, Multiple Myeloma, and Hodgkin Lymphoma, by Region, 2012?2018
Table 76 Plasma-Derived Products and Their Applications in Hemato-Oncology
Table 77 Plasma Fractionation Market for Hemato-Oncology, by Country, 2018-2025 (USD Million)
8.8 Rheumatology
8.8.1 Increasing Prevalence of Rheumatic Conditions to Drive the Plasma Fractionation Market for Rheumatology
Table 78 Plasma Fractionation Market for Rheumatology, by Country, 2018-2025 (USD Million)
8.9 Other Applications
Table 79 Plasma-Derived Products for Other Applications
Table 80 Plasma Fractionation Market for Other Applications, by Country, 2018-2025 (USD Million)

9 Plasma Fractionation Market, by End-user
9.1 Introduction
Table 81 Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
9.2 Hospitals & Clinics
9.2.1 Improving Healthcare Infrastructure and Growth in the Number of Hospitals & Clinics-Key Factors Driving Growth
Table 82 Plasma Fractionation Market for Hospitals & Clinics, by Country, 2018-2025 (USD Million)
9.3 Clinical Research Laboratories
9.3.1 Increasing Number of Clinical Studies on New Therapeutic Indications for Plasma-Derived Products to Drive Market Growth
Table 83 Clinical Studies on Albumin & Immunoglobulin, by Region (2017)
Table 84 Plasma Fractionation Market for Clinical Research Laboratories, by Country, 2018-2025 (USD Million)
9.4 Academic Institutes
9.4.1 Growing Demand for New Drug Molecules to Drive the Demand for Plasma Products in Academic Institutes
Table 85 Plasma Fractionation Market for Academic Institutes, by Country, 2018-2025 (USD Million)

10 Plasma Fractionation Market, by Region
10.1 Introduction
Table 86 Plasma Fractionation Market, by Region, 2018-2025 (USD Million)
10.2 North America
Figure 22 North America: Plasma Fractionation Market Snapshot
Table 87 North America: Plasma Fractionation Market, by Country, 2018-2025 (USD Million)
Table 88 North America: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 89 North America: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 90 North America: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 91 North America: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 92 North America: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.2.1 US
10.2.1.1 the US Dominates the Global Plasma Fractionation Market
Table 93 Us: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 94 Us: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 95 Us: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 96 Us: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 97 Us: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.2.2 Canada
10.2.2.1 Canada is Among the World's Highest Per Capita Users of IVIG
Table 98 Canada: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 99 Canada: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 100 Canada: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 101 Canada: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 102 Canada: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.3 Europe
Table 103 Plasma Fractionation Plants in Europe (2017)
Table 104 Europe: Plasma Fractionation Market, by Country, 2018-2025 (USD Million)
Table 105 Europe: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 106 Europe: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 107 Europe: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 108 Europe: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 109 Europe: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.3.1 Germany
10.3.1.1 Germany Has the Highest Plasma Fractionation Capacity in Europe
Table 110 Germany: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 111 Germany: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 112 Germany: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 113 Germany: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 114 Germany: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.3.2 France
10.3.2.1 High Prevalence of Bleeding Disorders to Drive the Market for Plasma Fractionation in France
Table 115 Number of People with Bleeding Disorders in France, 2012-2018
Table 116 France: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 117 France: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 118 France: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 119 France: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 120 France: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.3.3 Italy
10.3.3.1 Growth in the Country's Geriatric Population to Drive the Market for Plasma Fractionation
Table 121 Production of Plasma Products in Italy (2013, 2018-E, & 2023-E)
Table 122 Italy: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 123 Italy: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 124 Italy: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 125 Italy: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 126 Italy: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.3.4 Spain
10.3.4.1 Growing Demand for Plasma Products for the Treatment of Chronic Diseases in the Elderly is the Key Factor Driving Market Growth
Table 127 Spain: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 128 Spain: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 129 Spain: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 130 Spain: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 131 Spain: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.3.5 UK
10.3.5.1 Increasing Incidence of Hemophilia and the Growing Consumption of Coagulation Factors to Drive Market Growth in the UK
Table 132 Estimated Number of Hemophilia a and Hemophilia B Patients in the UK, 2012-2018
Table 133 Uk: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 134 Uk: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 135 Uk: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 136 Uk: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 137 Uk: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.3.6 Rest of Europe
Table 138 RoE: Number of Hemophilia Patients, by Country, 2012-2018
Table 139 RoE: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 140 RoE: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 141 RoE: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 142 RoE: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 143 RoE: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.4 Asia-Pacific
Figure 23 APAC: Plasma Fractionation Market Snapshot
Table 144 Asia-Pacific: Plasma Fractionation Market, by Country, 2018-2025 (USD Million)
Table 145 Asia-Pacific: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 146 Asia-Pacific: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 147 Asia-Pacific: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 148 Asia-Pacific: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 149 Asia-Pacific: Plasma Fractionation Market, by End-user, 2019-2025 (USD Million)
10.4.1 China
10.4.1.1 Rising Incidence of Diseases Such as Liver Cancer and Hepatitis B to Drive Market Growth in China
Table 150 China: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 151 China: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 152 China: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 153 China: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 154 China: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.4.2 Japan
10.4.2.1 Rising Prevalence of Neurological Disorders and Hematological Diseases Will Support Market Growth in the Country
Table 155 Mean Per Capita Factor Viii and Ix Use in Japan, 2014 Vs.2018 (In Iu/Total Population
Table 156 Patients with Bleeding Disorders in Japan, 2014 Vs. 2018
Table 157 Japan: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 158 Japan: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 159 Japan: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 160 Japan: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 161 Japan: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.4.3 Australia
10.4.3.1 Growing Demand for Plasma Products for the Treatment of Chronic Disease to Drive Market Growth
Table 162 Total Ig (Grams  Used in Australia, 2008/09-2017/18
Table 163 Australian Government Funding for the Supply of Blood and Blood Products, 2008-2018 (USD Million)
Figure 24 Fresh Blood Expenditure in Australia, 2008-2018 (USD Million)
Table 164 Australia: Blood Sector Overview (2017
Table 165 Australia: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 166 Australia: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 167 Australia: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 168 Australia: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 169 Australia: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.4.4 India
10.4.4.1 Growing Healthcare Awareness, Availability of Better Diagnostic Tools, and the Rising Geriatric Population to Drive Market Growth
Table 170 India: Number of Patients with Bleeding Disorders, 2012-2018
Table 171 India: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 172 India: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 173 India: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 174 India: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 175 India: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.4.5 Vietnam
10.4.5.1 Growing Pool of Patients Suffering from Copd, Pid, and Bleeding Disorders to Drive Market Growth
Figure 25 Mean Per Capita Use of Factor Viii and Ix in Vietnam, 2014-2018 (Iu/Population
Figure 26 Patient Population Suffering from Bleeding Disorders in Vietnam, 2014-2018
Table 176 Vietnam: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 177 Vietnam: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 178 Vietnam: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 179 Vietnam: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 180 Vietnam: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.4.6 Indonesia
10.4.6.1 Growing Government Initiatives to Drive Market Growth
Table 181 Indonesia: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 182 Indonesia: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 183 Indonesia: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 184 Indonesia: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 185 Indonesia: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.4.7 Malaysia
10.4.7.1 Increasing Prevalence of Bleeding Disorders Will Support the Plasma Fractionation Market in Malaysia
Table 186 Malaysia: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 187 Malaysia: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 188 Malaysia: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 189 Malaysia: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 190 Malaysia: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.4.8 Rest of Asia-Pacific
Table 191 Rest of Asia-Pacific: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 192 Rest of Asia-Pacific: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 193 Rest of Asia-Pacific: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 194 Rest of Asia-Pacific: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 195 Rest of Asia-Pacific: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.5 Latin America
10.5.1 Implementation of Government Initiatives to Promote Healthcare Services Will Drive Market Growth in Latin America
Table 196 Latin America: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 197 Latin America: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 198 Latin America: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 199 Latin America: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 200 Latin America: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.6 Middle East & Africa
Table 201 Hemophilia Patients in the Middle East and Africa, by Country, 2012-2018
Table 202 Per Capita Consumption of Factor Ix and Viii (Iu/Total Population  in South Africa, Saudi Arabia, and Iraq, 2012-2018)
Table 203 Middle East & Africa: Plasma Fractionation Market, by Country, 2018-2025 (USD Million)
Table 204 Middle East & Africa: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 205 Middle East & Africa: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 206 Middle East & Africa: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 207 Middle East & Africa: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 208 Middle East & Africa: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.6.1 Turkey
10.6.1.1 Turkey Dominates the Plasma Fractionation Market in the Middle East and Africa
Table 209 Turkey: Demographic Indicators
Table 210 Turkey: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 211 Turkey: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 212 Turkey: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 213 Turkey: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 214 Turkey: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.6.2 Saudi Arabia
10.6.2.1 Developments in Healthcare Infrastructure to Support Market Growth
Table 215 Saudi Arabia: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 216 Saudi Arabia: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 217 Saudi Arabia: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 218 Saudi Arabia: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 219 Saudi Arabia: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.6.3 Egypt
10.6.3.1 Growing Research on Plasma and Plasma Derivatives Will Support Market Growth
Table 220 Egypt: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 221 Egypt: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 222 Egypt: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 223 Egypt: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 224 Egypt: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.6.4 Uae
10.6.4.1 Growing Government Initiatives for Healthcare Infrastructure Development to Drive Market Growth in the Uae
Table 225 Uae: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 226 Uae: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 227 Uae: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 228 Uae: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 229 Uae: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)
10.6.5 Rest of the Middle East and Africa
Table 230 Hemophilia Patients in the Rest of Middle East and Africa, 2012?2018
Table 231 Romea: Plasma Fractionation Market, by Product, 2018-2025 (USD Million)
Table 232 Romea: Immunoglobulins Market, by Type, 2018-2025 (USD Million)
Table 233 Romea: Coagulation Factor Concentrates Market, by Type, 2018-2025 (USD Million)
Table 234 Romea: Plasma Fractionation Market, by Application, 2018-2025 (USD Million)
Table 235 Romea: Plasma Fractionation Market, by End-user, 2018-2025 (USD Million)

11 Competitive Landscape
11.1 Overview
11.2 Market Evaluation Framework
Table 236 Growth Strategy Matrix: Expansions and Collaborations Are the Widely Adopted Growth Strategies by Market Players 215
11.3 Competitive Scenario and Trends
Table 237 Product Launches & Approvals, January 2017?July 2020
Table 238 Expansions, January 2017?July 2020
Table 239 Acquisitions, January 2017?July 2020
Table 240 Agreements, Collaborations, and Partnerships, January 2017?July 2020

12 Company Evaluation Matrix and Company Profiles
12.1 Company Evaluation Matrix Definition and Methodology
12.1.1 Market Share Analysis
Figure 27 Plasma Fractionation Market Share Analysis, by Key Player, 2019
12.1.2 Market Share Analysis, by Product, 2019
12.1.2.1 Immunoglobulins Market, by Key Player
12.1.2.1.1 Ivig Market, by Key Player
12.1.2.2 Coagulation Factors Market, by Key Player
12.1.2.2.1 Factor Viii Market, by Key Player
12.1.2.3 Albumins Market, by Key Player
12.1.3 Market Share Analysis, by Region, 2019
12.1.3.1 North America: Plasma Fractionation Market, by Key Player
12.1.3.1.1 Us: Plasma Fractionation Market, by Key Player
12.1.3.2 Europe: Plasma Fractionation Market, by Key Player
12.2 Company Evaluation Matrix
12.2.1 Stars
12.2.2 Emerging Leaders
12.2.3 Pervasive
12.2.4 Emerging Companies
Figure 28 Competitive Leadership Mapping
12.3 Company Profiles
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, Analyst's View)*
12.3.1 Csl
Figure 29 Csl: Company Snapshot (2019)
12.3.2 Grifols
Figure 30 Grifols: Company Snapshot (2019)
12.3.3 Shire
Figure 31 Takeda Pharmaceuticals: Company Snapshot (2019)
12.3.4 Octapharma
Figure 32 Octapharma: Company Snapshot (2019)
12.3.5 Kedrion
Figure 33 Kedrion: Company Snapshot (2019)
12.3.6 LFB
Figure 34 LFB: Company Snapshot (2016)
12.3.7 Biotest
Figure 35 Biotest: Company Snapshot (2019)
12.3.8 Sanquin
Figure 36 Sanquin: Company Snapshot (2018)
12.3.9 China Biologic Products
Figure 37 China Biologic Products: Company Snapshot (2019)
12.3.10 Bio Products Laboratory
12.3.11 Japan Blood Products Organization
Figure 38 Japan Blood Products Organization: Company Snapshot (2019)
12.3.12 Gc Pharma
Figure 39 Gc Pharma: Company Snapshot (2019)
12.3.13 Shanghai Raas Blood Products
12.3.14 Emergent Biosolutions
Figure 40 Emergent Biosolutions: Company Snapshot (2019)
12.3.15 Intas Biopharmaceuticals
Figure 41 Intas Biopharmaceuticals: Company Snapshot (2019)
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, Analyst's View Might Not be Captured in Case of Unlisted Companies
12.3.16 Other Companies
12.3.16.1 Bharat Serums and Vaccines Limited
12.3.16.2 Sk Plasma
12.3.16.3 Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.
12.3.16.4 Kabafusion
12.3.16.5 Centurion Pharma

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Bharat Serums and Vaccines Limited (India)
  • Bio Products Laboratory (UK)
  • Biotest (Germany)
  • CSL (Australia)
  • Centurion Pharma (Turkey)
  • China Biologic Products (UK)
  • Emergent BioSolutions (US)
  • Green Cross Corporation (South Korea)
  • Grifols (Spain)
  • Intas Biopharmaceuticals (India)
  • Japan Blood Products Organization (Japan)
  • KabaFusion (US)
  • Kedrion (Italy)
  • LFB (France)
  • Octapharma (Switzerland)
  • SK Plasma (Republic of Korea)
  • Sanquin (Netherlands)
  • Shanghai RAAS Blood Products (China)
  • Shire (Ireland)
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China)
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll